Robert L. Findling, M.D., M.B.A.

Robert L. Findling, M.D., M.B.A.
Robert Findling
Vice President of Psychiatric Services and Research

Kennedy Krieger Institute
716 North Broadway, Room 208
Baltimore, MD 21205
Phone: (443) 923-7727
Email: findling@kennedykrieger.org

Dr. Findling is the Vice President of Psychiatric Services and Research at the Kennedy Krieger Institute. He is also the Director of Child & Adolescent Psychiatry, a Vice Chair in the Department of Psychiatry and Behavioral Sciences, and a Professor (PAR) at Johns Hopkins. Dr. Findling is working to foster and integrate the faculties, services and research opportunities at Kennedy Krieger, Johns Hopkins Hospital and the affiliated programs at Bayview Medical Center.


Biographical Sketch:

Dr. Findling did his undergraduate work at Johns Hopkins University and went to medical school at the Medical College of Virginia. Dr. Findling then completed training in Pediatrics, Psychiatry, and Child & Adolescent Psychiatry as part of the “Triple Board” joint training program at Mt. Sinai in New York. He subsequently earned his Masters of Business Administration degree at a joint program run by the London School of Economics, NYU Stern, and HEC Paris called “Trium”.

After serving as the Rocco L. Motto, M.D. Chair of Child and Adolescent Psychiatry at Case Western Reserve University School of Medicine and Director of the Division of Child and Adolescent Psychiatry at University Hospitals Case Medical Center, Dr. Findling returned to Baltimore in 2012. 


Research Summary:

Dr. Findling has achieved international recognition as a clinician and an educator. His investigative endeavors have focused on pediatric psychopharmacology and serious psychiatric disorders in the young. Dr. Findling has authored over 300 scientific articles as well as several books.  His research is supported by the National Institutes of Health, the Stanley Medical Research Institute, and the pharmaceutical industry. 


Research Studies:

Dr. Findling serves as both a principal investigator and co-investigator on numerous research protocols in both typically-developing and atypically-developing children that are being conducted under the auspices of Kennedy Krieger’s Clinical Trials Unit.